MGIM
PACB icon

M&G Investment Management’s Pacific Biosciences PACB Stock Holding History

M&G Investment Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-86,196
Closed -$2.24M – 668
2021
Q3 		$2.24M Buy
86,196
+72,012
+508% +$2.13M 0.01% 502
2021
Q2 		$496K Buy
+14,184
New +$413K ﹤0.01% 678

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

M&G Investment Management's PACB Position: Q4 2021 in Review

M&G Investment Management sold out of Pacific Biosciences (PACB) in Q4 2021, closing a stake of 86,196 shares — an estimated $2.24M sold.

M&G Investment Management first reported a position in PACB in Q2 2021 and held it in 2 quarters. The position peaked at $2.24M in Q3 2021. 255 funds tracked by Wall St. Rank hold PACB as of Q4 2021.

  • M&G Investment Management reported no remaining Pacific Biosciences position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 86,196 Pacific Biosciences shares in Q4 2021, an estimated $2.24M.
  • M&G Investment Management first reported a position in Pacific Biosciences in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's Pacific Biosciences position peaked at $2.24M in Q3 2021.
  • 255 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.